Federal Reports

The Office of Inspector General (OIG) is initiating an audit of the AbilityOne Commission’s ERM Process. Our overall objective is to determine if the Commission's ERM process is effective and used to make risk-based decisions.

To view the report, please click on the link below.

Semiannual Report to the Congress April 1, 2023 - September 30, 2023

This report summarizes work we initiated and completed during this semiannual period on a number of critical U.S. Department of Commerce (Department) activities. Over the past 6 months, our office issued 10 products related to our audit, evaluation, and inspection work. These products addressed programs and personnel associated with the U.S. Census Bureau, U.S. Economic Development Administration (EDA), National Oceanic and Atmospheric Administration (NOAA), National Telecommunications and Information Administration, United States Patent and Trademark Office, and the Department itself. This report also describes our investigative activities addressing programs and personnel associated with the Census Bureau, EDA, NOAA, and the Department.

Semiannual Report to Congress for the period April 1, 2023 – September 30, 2023

Without enforcing established access control requirements, the EPA puts the chemical data, which IRIS users rely upon to inform scientifically sound environmental regulations and policies, at risk of unauthorized changes.

The VA Office of Inspector General (OIG) conducted a healthcare inspection to assess an allegation that facility leaders failed to complete clinical and institutional disclosures for three identified patients. The OIG substantiated that one of the three patients received a delayed institutional disclosure and did not receive a clinical disclosure. The OIG found that the delay in the institutional disclosure occurred because the Chief of Staff established a process to have a peer review conducted prior to determining if an institutional disclosure was warranted. The other two patients received clinical disclosures.During the inspection, the OIG identified concerns related to deficiencies in quality management and safety processes, including failure to enter events into the Joint Patient Safety Reporting system and review adverse events, failure to initiate a required root cause analysis, and insufficient documentation and explanation of decision-making within Peer Review Committee meeting minutes. Additionally, the OIG determined that facility providers failed to properly communicate abnormal imaging and laboratory test results to patients as required by policy.The OIG made five recommendations to the Facility Director related to conducting and documenting clinical disclosures; evaluating quality management processes that impede the timeliness of conducting institutional disclosures; adhering to Peer Review Committee documentation standards; ensuring adverse events or close calls are entered into the system, reviewed, and required actions are conducted per policy; and evaluating the process for the communication of abnormal test results to patients.